Literature DB >> 8880200

Biology and management of AIDS-associated primary CNS lymphomas.

P A Forsyth1, L M DeAngelis.   

Abstract

Primary central nervous system (CNS) lymphoma is the most common brain tumor in patients with AIDS and occurs in about 10% of this population. CT/MR scan usually demonstrates single or multiple contrast enhancing masses that are radiographically indistinguishable from other CNS processes such as toxoplasmosis. Brain biopsy, positive cerebrospinal fluid (CSF) cytology, or possibly the demonstration of Epstein-Barr viral DNA in the CSF can establish the diagnosis. Cranial radiotherapy (RT) has been the cornerstone of therapy and produces responses in most patients, but their median survival is still only a few months. The addition of chemotherapy to RT may prolong survival in a sub-group of patients.

Entities:  

Mesh:

Year:  1996        PMID: 8880200     DOI: 10.1016/s0889-8588(05)70388-9

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  9 in total

Review 1.  Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

Authors:  Chi-Chao Chan; James L Rubenstein; Sarah E Coupland; Janet L Davis; J William Harbour; Patrick B Johnston; Nathalie Cassoux; Valerie Touitou; Justine R Smith; Tracy T Batchelor; Jose S Pulido
Journal:  Oncologist       Date:  2011-11-01

2.  AIDS-related central nervous system lymphomas.

Authors:  M C Chamberlain; P A Kormanik
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 3.  The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases.

Authors:  Alfred O Ankrah; Andor W J M Glaudemans; Hans C Klein; Rudi A J O Dierckx; Mike Sathekge
Journal:  Nucl Med Mol Imaging       Date:  2016-05-25

4.  Primary central nervous system lymphoma--a hospital based study of incidence and clinicopathological features from India (1980-2003).

Authors:  Chitra Sarkar; Mehar Chand Sharma; Prabal Deb; Rajbir Singh; Vani Santosh; S K Shankar
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

5.  Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy.

Authors:  Neel K Gupta; Chia-Ching Wang; Gabriel N Mannis; John-Paul J Yu; James L Rubenstein
Journal:  Leuk Lymphoma       Date:  2017-04-10

6.  Long-term survival in AIDS-related primary central nervous system lymphoma.

Authors:  Neel K Gupta; Amber Nolan; Antonio Omuro; Erin G Reid; Chia-Ching Wang; Gabriel Mannis; Michael Jaglal; Julio C Chavez; Paul G Rubinstein; Ann Griffin; Donald I Abrams; Jimmy Hwang; Lawrence D Kaplan; Judith A Luce; Paul Volberding; Patrick A Treseler; James L Rubenstein
Journal:  Neuro Oncol       Date:  2016-08-30       Impact factor: 12.300

7.  Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients.

Authors:  Delia Kurzwelly; Claudia A Müller; Agnieszka Korfel; Eckhard Thiel; Michael Linnebank; Michael Weller; Ulrich Herrlinger
Journal:  J Neurooncol       Date:  2008-06-28       Impact factor: 4.130

Review 8.  Intraocular lymphoma: a clinical perspective.

Authors:  J L Davis
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

9.  Primary central nervous system diffuse large B-cell lymphoma in the immunocompetent: Immunophenotypic subtypes and Epstein-Barr virus association.

Authors:  Anita Mahadevan; Clementina Rama Rao; M Shanmugham; Susarla Krishna Shankar
Journal:  J Neurosci Rural Pract       Date:  2015-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.